Clinical trial
Analysis of Changes in Intestinal Flora of Hyperlipidemia by Ezetimibe and Orlistat.
NCT03884127 is registered in ClinicalTrials.gov with Fifth Affiliated Hospital of Xinjiang Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of Changes in Intestinal Flora of Hyperlipidemia by Ezetimibe and Orlistat.
- Lead sponsor
- Fifth Affiliated Hospital of Xinjiang Medical University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 1, 2019
- Completion date
- September 30, 2019
- Enrollment
- 58 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hyperlipidemia